Increased levels of IL‐17 in tear fluid of moderate‐to‐severe psoriatic patients is reduced by adalimumab therapy. (19th October 2015) - Chiricozzi, A.; Cannizzaro, M.V.; Salandri, G.A.; Marinari, B.; Pitocco, R.; Dattola, A.; Regine, F.; Saraceno, R.; Bianchi, L.; Chimenti, S.; Costanzo, A.